Digitalization Driving Next-Generation Patient Treatments

Advanced therapies hold extraordinary potential to transform patient care across a wide range of diseases. The field is undergoing rapid evolution, driven by scientific and technological progress and the growing need for scalable, patient-centric solutions. In this context, digitalization and automation is emerging as a key enabler — helping to reduce manufacturing risks, lower operational costs, and deliver the consistency required to make cell therapies reliably and broadly accessible to patients. This event brings together leading voices from politics, research, and industry to discuss how automation and digital innovation can accelerate progress and strengthen the biotechnology landscape in Germany.